1.78
price down icon0.84%   -0.015
after-market Handel nachbörslich: 1.78
loading
Schlusskurs vom Vortag:
$1.795
Offen:
$1.78
24-Stunden-Volumen:
406.30K
Relative Volume:
0.63
Marktkapitalisierung:
$66.83M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+1.71%
1M Leistung:
-21.24%
6M Leistung:
+7.23%
1J Leistung:
-3.78%
1-Tages-Spanne:
Value
$1.73
$1.82
1-Wochen-Bereich:
Value
$1.54
$1.83
52-Wochen-Spanne:
Value
$1.23
$4.92

Metagenomi Inc Stock (MGX) Company Profile

Name
Firmenname
Metagenomi Inc
Name
Telefon
(510) 871-4880
Name
Adresse
5959 HORTON STREET, EMERYVILLE
Name
Mitarbeiter
124
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
MGX's Discussions on Twitter

Vergleichen Sie MGX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MGX
Metagenomi Inc
1.78 67.21M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
455.48 116.04B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
718.36 75.97B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
458.12 61.48B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
901.17 56.40B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
204.00 43.73B 447.02M -1.18B -906.14M -6.1812

Metagenomi Inc Stock (MGX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-07 Eingeleitet H.C. Wainwright Buy
2024-05-02 Herabstufung JP Morgan Overweight → Neutral
2024-03-05 Eingeleitet BMO Capital Markets Outperform
2024-03-05 Eingeleitet Chardan Capital Markets Buy
2024-03-05 Eingeleitet JP Morgan Overweight
2024-03-05 Eingeleitet Jefferies Buy
2024-03-05 Eingeleitet TD Cowen Outperform
2024-03-05 Eingeleitet Wells Fargo Overweight
Alle ansehen

Metagenomi Inc Aktie (MGX) Neueste Nachrichten

pulisher
Dec 02, 2025

Will Metagenomi Inc. stock deliver consistent dividendsBull Run & Technical Pattern Based Signals - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Pura Vida Investments LLC Grows Stock Position in Metagenomi, Inc. $MGX - MarketBeat

Dec 02, 2025
pulisher
Dec 02, 2025

Metagenomi’s general counsel Wein sells $360 in stock By Investing.com - Investing.com Nigeria

Dec 02, 2025
pulisher
Dec 01, 2025

Thomas Brian C. sells Metagenomi (MGX) shares worth $4888 By Investing.com - Investing.com Canada

Dec 01, 2025
pulisher
Dec 01, 2025

Irish Jian, Metagenomi CEO, sells $2899 in MGX stock By Investing.com - Investing.com Canada

Dec 01, 2025
pulisher
Dec 01, 2025

Metagenomi CFO Wapnick sells $2852 in shares By Investing.com - Investing.com Canada

Dec 01, 2025
pulisher
Dec 01, 2025

Thomas Brian C. sells Metagenomi (MGX) shares worth $4888 - Investing.com India

Dec 01, 2025
pulisher
Dec 01, 2025

Metagenomi CFO Wapnick sells $2852 in shares - Investing.com

Dec 01, 2025
pulisher
Dec 01, 2025

Irish Jian, Metagenomi CEO, sells $2899 in MGX stock - Investing.com

Dec 01, 2025
pulisher
Dec 01, 2025

CEO Irish Surrenders 1,602 Of Metagenomi Inc [MGX] - TradingView

Dec 01, 2025
pulisher
Dec 01, 2025

Metagenomi’s general counsel Wein sells $360 in stock - Investing.com

Dec 01, 2025
pulisher
Dec 01, 2025

Metagenomi (Nasdaq: MGX) to unveil APOC3 preclinical data from Ionis collaboration at 2025 Nature conference - Stock Titan

Dec 01, 2025
pulisher
Nov 29, 2025

Why analysts upgrade Metagenomi Inc. stock2025 Technical Overview & Free Real-Time Market Sentiment Alerts - BỘ NỘI VỤ

Nov 29, 2025
pulisher
Nov 29, 2025

Will Metagenomi Inc. stock attract ESG investorsQuarterly Earnings Report & Reliable Intraday Trade Plans - BỘ NỘI VỤ

Nov 29, 2025
pulisher
Nov 28, 2025

Metagenomi, Inc. (MGX) 5.71% in After-hours: Strong Investor Interest - Stocks Telegraph

Nov 28, 2025
pulisher
Nov 22, 2025

Metagenomi Inc Stock Analysis and ForecastMomentum Trading Signals & Predict Price Movements With AI Precision - earlytimes.in

Nov 22, 2025
pulisher
Nov 20, 2025

Why Metagenomi Inc. stock could rally in 2025July 2025 Volume & Verified High Yield Trade Plans - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Market reaction to Metagenomi Inc.’s recent newsLong Setup & Weekly Setup with ROI Potential - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What sentiment indicators say about Metagenomi Inc. stockJuly 2025 Movers & Technical Pattern Based Buy Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How to forecast Metagenomi Inc. trends using time seriesBull Run & Free Expert Approved Momentum Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Metagenomi Inc. stock a safe haven assetQuarterly Trade Review & Free Daily Entry Point Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Metagenomi Inc. stock performs in stagflationQuarterly Profit Report & Capital Efficiency Focused Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Metagenomi Inc. stock gaining market shareJuly 2025 Breakouts & Technical Buy Zone Confirmations - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Exit strategy if you’re trapped in Metagenomi Inc.Market Trend Review & Weekly Hot Stock Watchlists - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

How Metagenomi Inc. stock performs in rising dollar environmentJuly 2025 Selloffs & Expert-Curated Trade Recommendations - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Using AI based signals to follow Metagenomi Inc.July 2025 Market Mood & Low Drawdown Momentum Ideas - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Ready to Jump After Recent Trade: Metagenomi Inc (MGX) - Setenews

Nov 18, 2025
pulisher
Nov 18, 2025

Jefferies lowers Metagenomi stock price target to $9 from $21 on pipeline timing - Investing.com Nigeria

Nov 18, 2025
pulisher
Nov 17, 2025

Metagenomi to Present at Jefferies Global Healthcare Conference in London - The Manila Times

Nov 17, 2025
pulisher
Nov 16, 2025

The Impact Of Rising Infectious Disease Incidence On - openPR.com

Nov 16, 2025
pulisher
Nov 16, 2025

Metagenomi, Inc. (NASDAQ:MGX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 16, 2025
pulisher
Nov 14, 2025

Rx Rundown: Metagenomi, Chiesi, Thermo Fisher Scientific and more - Medical Marketing and Media

Nov 14, 2025

Finanzdaten der Metagenomi Inc-Aktie (MGX)

Es liegen keine Finanzdaten für Metagenomi Inc (MGX) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$39.73
price up icon 1.44%
$31.74
price down icon 0.91%
$102.52
price up icon 2.03%
$96.25
price up icon 0.27%
biotechnology ONC
$322.90
price down icon 2.53%
$204.00
price down icon 0.51%
Kapitalisierung:     |  Volumen (24h):